QSAR studies on 2-(benzyl)imidazoline analogs as h5-HT1D/1B serotonin receptor ligands

T. Prisinzano, H. Law, A. Slassi, N. Maclean, L. Demchyshyn, R. A. Glennon

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Human 5-HT1D/1B receptors are the likely therapeutic targets of several clinically used migraine-abortive triptans such as sumatriptan. The present investigation, using several QSAR methods (e.g. CoMFA and Hansch analysis), attempts to better explain the structure-affinity relationships of 2-(benzyl)imidazolines and benzylimidazoline-related compounds for binding at h5-HT1D receptors. It was found that lipophilicity at the 4-position of benzylimidazolines correlates well both with h5-HT1D and h5-HT1B receptor affinity.

Original languageEnglish
Pages (from-to)309-317
Number of pages9
JournalMedicinal Chemistry Research
Volume10
Issue number5
StatePublished - 2001

ASJC Scopus subject areas

  • General Pharmacology, Toxicology and Pharmaceutics
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'QSAR studies on 2-(benzyl)imidazoline analogs as h5-HT1D/1B serotonin receptor ligands'. Together they form a unique fingerprint.

Cite this